4BB.L

4basebio PLC
LSEGBpEQUITY Healthcare DELAYED
Last price
470.00
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
490.00
Prev close
470.00
Day high
0.00
Day low
0.00
Volume
9
Market cap
$72.78M
P/E (TTM)
52W range
0.00 – 920.00

Day trading desk

Current session · delayed
Gap from prior close
+5.38%
Prior close 465.00
VWAP
481.59
-2.41% from price
Relative volume
0.14×
Quiet session
Session range
8.89%
450.00 – 490.00
Position in range
50%
Mid range
ATR (14D)
29.78
6.34% of price
Prior day high
480.00
PDH
Prior day low
450.00
PDL
Bid / ask spread
Quote not published
Session volume
130
Avg 923

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-14.55% -13.4%
1M
-10.48% -13.8%
3M
-3.09% -5.5%
6M
-15.32% -27.2%
YTD
-23.58% -35.5%
1Y
-46.89% -67.0%
3Y
-23.58% -98.6%
5Y
-31.88%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on 4BB.L open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
9.41M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
May 21, 26
Walker (Amy Jo)
BUY 1.86K $12.73K Direct
Feb 24, 26
Lanckriet (Heikki)
0 Direct
Feb 24, 26
Latonba AG
0 Direct
Feb 24, 26
M&G Investment Management Ltd
0 Direct
Feb 24, 26
Sparta AG
0 Direct
Feb 24, 26
4bb AG
0 Direct
Feb 24, 26
De Busschere (Franciscus)
0 Direct
Feb 24, 26
Delphi Unternehmensberatung Aktiengesellschaft
0 Direct
Feb 24, 26
Deutsche Balaton Aktiengesellschaft
0 Direct
Feb 24, 26
Elevage Medical Technologies LP
0 Direct
Feb 13, 26
Walker (Amy Jo)
BUY 2.65K $21.19K Direct
Feb 10, 26
Lanckriet (Heikki)
BUY 3.00K $23.57K Direct
Feb 10, 26
Plaggemars (Hansjoerg)
BUY 1.00K $7.98K Direct
Sep 29, 25
Lanckriet (Heikki)
BUY 2.00K $20.14K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
4bb AG
2.23M Annual Return
De Busschere (Franciscus)
537.25K Annual Return
Delphi Unternehmensberatung Aktiengesellschaft
638.44K Annual Return
Elevage Medical Technologies LP
2.67M Annual Return
Fernandez (Joseph Manuel)
335.20K Sold
Lanckriet (Heikki)
1.11M Annual Return
Latonba AG
792.74K Annual Return
M&G Investment Management Ltd
1.96M Annual Return
Roth (David John)
355.87K Sold
Sparta AG
1.35M Annual Return

Fundamentals

TTM · reported
Market cap$72.78M
Enterprise value$71.71M
Revenue (TTM)$1.69M
Gross profit$974.00K
EBITDA$-15.74M
Net income$-16.91M
EPS (TTM)$-1.09
Free cash flow$-12.15M
Total cash$18.04M
Total debt$16.72M
Book value / share$0.65
Shares outstanding15.48M
Float5.74M
Short % of float
Dividend yield
Beta (5Y)0.87

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E-7.83
PEG ratio
Price / sales
Price / book721.97
EV / revenue42.36
EV / EBITDA-4.55
Gross margin57.53%
Operating margin-1604.24%
Profit margin0.00%
Return on equity-92.65%
Return on assets-28.04%
Debt / equity165.38
Current ratio7.31
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 3 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $1.69M$933.00K$506.00K$268.00K +81.5%
Operating revenue $1.69M$933.00K$506.00K$268.00K +81.5%
Cost of revenue $719.00K$303.00K$166.00K$29.00K +137.3%
Gross profit $974.00K$630.00K$340.00K$239.00K +54.6%
Research & development $5.12M$4.68M$2.22M$2.08M +9.4%
Selling, general & admin $2.25M$1.76M$1.09M$1.43M +27.6%
Total operating expense $17.64M$13.42M$8.51M$5.91M +31.4%
Operating income -$16.66M-$12.79M-$8.17M-$5.67M -30.3%
Net interest income -$3.00K-$612.00K-$302.00K-$89.00K +99.5%
Pre-tax income -$17.60M-$12.65M-$8.35M-$5.93M -39.1%
Tax provision -$698.00K-$321.00K-$689.00K-$779.00K -117.4%
Net income -$16.91M-$12.33M-$7.67M-$5.15M -37.1%
Net income to common -$16.91M-$12.33M-$7.67M-$5.15M -37.1%
Basic EPS -1.09-0.94-0.62-0.42 -16.0%
Diluted EPS -1.09-0.94-0.62-0.42 -16.0%
EBIT -$16.72M-$11.90M-$8.05M-$5.84M -40.4%
EBITDA -$15.57M-$10.97M-$7.34M-$5.41M -42.0%
Basic shares 15.51M13.12M12.32M12.32M +18.2%
Diluted shares 15.51M13.12M12.32M12.32M +18.2%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year -1.00 2 $2.80M +65.4%
Next year -0.60 1 $12.00M +328.6%

Analyst targets & ownership

Account required
Mean target$1,600.00
High target$1,800.00
Low target$1,400.00
Implied upside240.43%
Analyst count2
ConsensusNONE
Strong buy / Buy1 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders60.56%
Held by institutions14.17%
Institutions holding4
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
505.40
-7.00% from price
SMA 20
515.20
-8.77% from price
SMA 50
521.48
-9.87% from price
SMA 100
509.16
-7.69% from price
SMA 200
558.87
-15.90% from price
EMA 12
498.76
-5.77% from price
EMA 26
511.04
-8.03% from price
EMA 50
515.48
-8.82% from price
RSI (14)
33.5
Neutral
MACD (12,26,9)
-12.28
Hist -7.56
ATR (14)
29.78
6.34% of price
Realised vol 30D
44.2%
Annualised
Bollinger upper
564.91
20, 2σ
Bollinger lower
465.49
20, 2σ
50 / 200 cross
Death
521.48 vs 558.87
Trend bias
Below 200
-15.90%

Options chain

Account required
Expiry
Spot 470.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.37
Less volatile than market
Correlation to SPY
-0.12
Largely independent
Realised vol 30D
44.2%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-50.8%
Peak to trough
Max drawdown 5Y
-76.1%
Peak to trough
ATR 14
29.78
6.34% of price
Beta (reported)
0.87
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.